Comparative investigation of the anti-emetic effects of granisetron and palonosetron during the treatment of acute myeloid leukemia.

about

Comparative investigation of the anti-emetic effects of granisetron and palonosetron during the treatment of acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q38601381

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Comparative investigation of t ...... ent of acute myeloid leukemia.

@en

type

Item

label

Comparative investigation of t ...... ent of acute myeloid leukemia.

@en

prefLabel

Comparative investigation of t ...... ent of acute myeloid leukemia.

@en

P1476

Comparative investigation of t ...... ent of acute myeloid leukemia.

@en

P2093

Aki Matsumaru

http://www.w3.org/2001/XMLSchema#string

Shinichi Ito

http://www.w3.org/2001/XMLSchema#string

Yutaka Tsutsumi

http://www.w3.org/2001/XMLSchema#string

P2860

Review of palonosetron: emerging data distinguishing it as a novel 5-HT(3) receptor antagonist for chemotherapy-induced nausea and vomiting.

Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings.

Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecut

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments.

Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)

Palonosetron: in the prevention of nausea and vomiting.

Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis.

P304

629-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2017.1350

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28855996

http://www.w3.org/2001/XMLSchema#string

P932

5574161

http://www.w3.org/2001/XMLSchema#string